135 related articles for article (PubMed ID: 19940491)
1. Adult outcomes of patients with juvenile idiopathic arthritis.
Minden K
Horm Res; 2009 Nov; 72 Suppl 1():20-5. PubMed ID: 19940491
[TBL] [Abstract][Full Text] [Related]
2. Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort.
Oen K; Duffy CM; Tse SM; Ramsey S; Ellsworth J; Chédeville G; Chetaille AL; Saint-Cyr C; Cabral DA; Spiegel LR; Schneider R; Lang B; Huber AM; Dancey P; Silverman E; Rosenberg AM; Cameron B; Johnson N; Dorval J; Scuccimarri R; Campillo S; Petty RE; Duffy KN; Boire G; Haddad E; Houghton K; Laxer R; Turvey SE; Miettunen P; Gross K; Guzman J; Benseler S; Feldman BM; Espinosa V; Yeung RS; Tucker L
Arthritis Care Res (Hoboken); 2010 Apr; 62(4):527-36. PubMed ID: 20391508
[TBL] [Abstract][Full Text] [Related]
3. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis.
Nordal E; Zak M; Aalto K; Berntson L; Fasth A; Herlin T; Lahdenne P; Nielsen S; Straume B; Rygg M;
Arthritis Rheum; 2011 Sep; 63(9):2809-18. PubMed ID: 21560116
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
Quartier P; Taupin P; Bourdeaut F; Lemelle I; Pillet P; Bost M; Sibilia J; Koné-Paut I; Gandon-Laloum S; LeBideau M; Bader-Meunier B; Mouy R; Debré M; Landais P; Prieur AM
Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553
[TBL] [Abstract][Full Text] [Related]
5. Effects of growth hormone treatment on growth in children with juvenile idiopathic arthritis.
Simon D; Bechtold S
Horm Res; 2009 Nov; 72 Suppl 1():55-9. PubMed ID: 19940497
[TBL] [Abstract][Full Text] [Related]
6. Update on treatment of arthritis in children: new treatments, new goals.
Lovell DJ
Bull NYU Hosp Jt Dis; 2006; 64(1-2):72-6. PubMed ID: 17121494
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
Prince FH; Twilt M; ten Cate R; van Rossum MA; Armbrust W; Hoppenreijs EP; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; van Suijlekom-Smit LW
Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443
[TBL] [Abstract][Full Text] [Related]
8. [Juvenile idiopathic arthritis].
Herlin T
Ugeskr Laeger; 2002 Aug; 164(34):3941-6. PubMed ID: 12212473
[TBL] [Abstract][Full Text] [Related]
9. Natural history of growth and body composition in juvenile idiopathic arthritis.
Bechtold S; Roth J
Horm Res; 2009 Nov; 72 Suppl 1():13-9. PubMed ID: 19940490
[TBL] [Abstract][Full Text] [Related]
10. Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids.
Simon D; Fernando C; Czernichow P; Prieur AM
J Rheumatol; 2002 Jun; 29(6):1296-300. PubMed ID: 12064849
[TBL] [Abstract][Full Text] [Related]
11. Juvenile idiopathic arthritis--current and future therapies.
Kahn P
Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
[TBL] [Abstract][Full Text] [Related]
12. Effect of inflammatory activity and glucocorticoid [corrected] use on nutritional variables in patients with juvenile idiopathic arthritis.
Souza L; Machado SH; Bredemeier M; Brenol JC; Xavier RM
J Rheumatol; 2006 Mar; 33(3):601-8. PubMed ID: 16511929
[TBL] [Abstract][Full Text] [Related]
13. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.
Tynjälä P; Vähäsalo P; Tarkiainen M; Kröger L; Aalto K; Malin M; Putto-Laurila A; Honkanen V; Lahdenne P
Ann Rheum Dis; 2011 Sep; 70(9):1605-12. PubMed ID: 21623000
[TBL] [Abstract][Full Text] [Related]
14. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.
Lurati A; Pontikaki I; Teruzzi B; Desiati F; Gerloni V; Gattinara M; Cimaz R; Fantini F
Arthritis Rheum; 2006 May; 54(5):1602-7. PubMed ID: 16646003
[TBL] [Abstract][Full Text] [Related]
15. New advances in the management of juvenile idiopathic arthritis--1: non-biological therapy.
Beresford MW; Baildam EM
Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):144-50. PubMed ID: 19770494
[TBL] [Abstract][Full Text] [Related]
16. Update on biologicals for treatment of juvenile idiopathic arthritis.
Horneff G
Expert Opin Biol Ther; 2013 Mar; 13(3):361-76. PubMed ID: 23289865
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome in patients with juvenile idiopathic arthritis.
Minden K; Niewerth M; Listing J; Biedermann T; Bollow M; Schöntube M; Zink A
Arthritis Rheum; 2002 Sep; 46(9):2392-401. PubMed ID: 12355487
[TBL] [Abstract][Full Text] [Related]
18. Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis.
Vojvodich PF; Hansen JB; Andersson U; Sävendahl L; Hagelberg S
J Rheumatol; 2007 Dec; 34(12):2481-5. PubMed ID: 18050366
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study.
Bechtold S; Ripperger P; Häfner R; Said E; Schwarz HP
J Pediatr; 2003 Oct; 143(4):512-9. PubMed ID: 14571231
[TBL] [Abstract][Full Text] [Related]
20. Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score.
Consolaro A; Bracciolini G; Ruperto N; Pistorio A; Magni-Manzoni S; Malattia C; Pederzoli S; Davì S; Martini A; Ravelli A;
Arthritis Rheum; 2012 Jul; 64(7):2366-74. PubMed ID: 22231288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]